MIRNA QUANTIFICATION IN PATIENTS WITH SEPTIC SHOCK

Recruiting Observational Study
Sepsis and Septic Shock
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
56 (estimated)
Sponsor
Insel Gruppe AG, University Hospital Bern · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Sepsis-induced immunosuppression (SIS) is a common complication in patients with septic shock. Reduced expression of Human leukocyte antigen isotype DR (HLA-DR) on circulating monocytes is a marker for SIS and correlates with risk of secondary infections and mortality. The miRSep study aims to improve the understanding of early microRNA (miRNA) mediated changes in HLA-DR on monocytes in patients w…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Septic shock: * New onset (\<24h) of septic shock diagnosis according to Sepsis-3 definition * (suspected) infection * Vasopressors required to maintain mean arterial pressure ≥65mm Hg (despite adequate fluid resuscitation) * Serum lactate level \> 2mmol/L * Minimum age of 18 y…
Contacts

No contact information available.